These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4893737)

  • 41. [Malaria chemoprophylaxis. Resistance problems].
    Danis M; Gentilini M
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():971-5. PubMed ID: 3914247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment and chemoprophylaxis of malaria.
    Spicer AJ
    Practitioner; 1979 Oct; 223(1336):521-6. PubMed ID: 392489
    [No Abstract]   [Full Text] [Related]  

  • 43. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study.
    Watkins WM; Brandling-Bennett AD; Nevill CG; Carter JY; Boriga DA; Howells RE; Koech DK
    Trans R Soc Trop Med Hyg; 1988; 82(3):398-403. PubMed ID: 3068855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with mixed infections of Plasmodium falciparum and vivax.
    Miller MB; Bratton JL; Hanson JP; Cohen M; Reynolds RD; Lohr DC; Hunt J; Jilek D
    Mil Med; 1973 Sep; 138(9):567 passim. PubMed ID: 4200077
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
    Schapira A; Schwalbach JF
    Bull World Health Organ; 1988; 66(2):219-26. PubMed ID: 3293827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human malaria (Plasmodium falciparum) in owl monkeys (Aotus trivirgatus).
    Voller A; Hawkey CM; Richards WH; Ridley DS
    J Trop Med Hyg; 1969 Jul; 72(7):153-60. PubMed ID: 4978679
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on anti-folate antimalarials in east Africa.
    Ortelli F; Maxwell CA; Curtis J; Watkins WM
    Parassitologia; 1999 Sep; 41(1-3):313-4. PubMed ID: 10697874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 51. The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria.
    Chin W; Contacos PG; Coatney GR; King HK
    Am J Trop Med Hyg; 1966 Nov; 15(6):823-9. PubMed ID: 5335159
    [No Abstract]   [Full Text] [Related]  

  • 52. Chloroquine-resistant malaria in Burma.
    Aung-Than-Batu ; Htun Nyun R; Hlaing N; Tin F; U T; Myint T; Kyi KK
    J Trop Med Hyg; 1975 Aug; 78(8):186-9. PubMed ID: 128638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia.
    Verdrager J
    J Trop Med Hyg; 1986 Dec; 89(6):277-89. PubMed ID: 3543384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy of malaria.
    Rozman RS
    Annu Rev Pharmacol; 1973; 13():127-52. PubMed ID: 4576886
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of dapsone with pyrimethamine (Maloprim) for malaria prophylaxis in Maputo, Mozambique.
    Pividal J; Viktinski V; Streat E; Schapira A
    East Afr Med J; 1992 Jun; 69(6):303-5. PubMed ID: 1505413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

  • 57. [Initial results with the use of Ro 6-4793-1 in the treatment of malaria].
    Nogueira RA; de Jesús SP; Leitão JM
    Hospital (Rio J); 1968 Sep; 74(3):979-85. PubMed ID: 5310134
    [No Abstract]   [Full Text] [Related]  

  • 58. Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment.
    Salako LA; Adio RA; Sowunmi A; Walker O
    Trans R Soc Trop Med Hyg; 1990; 84(5):641-3. PubMed ID: 2278060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistant malaria.
    Br Med J; 1971 Apr; 2(5755):185-6. PubMed ID: 5575949
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of malaria with pyrimethamine-sulformethoxine in association].
    Riche A
    Presse Med (1893); 1970 Oct; 78(46):2022. PubMed ID: 5482808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.